The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

A••••••• C•••••••••

Healthcare & Pharmaceuticalsgroup grade Aoff every schedule since Jun 30, 2023sponsor not established · possible relationship
Also written as: Undrawn Commitment

Nothing material in the last 200 days. Last change: 30 Jun 2023, Consensus mark 100¢ on cost, up from 98¢ in Q3 2022, 98¢ last quarter.

Mark path, consensus per quarter end
Q3 2022: 98¢Q4 2022: 98¢Q1 2023: 98¢Q2 2023: 100¢98¢ · 98¢ · 98¢ · 100¢Q3 2022 to Q2 2023
Where each lender marks it on the first lien term loan, 0 points apart
100¢Consensus: 100¢C•••••• C••••• S••••••••• I•••: 100¢C•••••• S•••••• L••••••• I•••: 100¢M••••• F•••••••• I••••••••• C•••: 100¢C••• I••••••••• C•••: 100¢100¢
Principal held
at least $73.3M
sum of BDC pieces, a lower bound
Fair value
$91.4M
100c on cost, debt pieces
Unfunded
$1.7M
commitments not yet drawn
BDC lenders
6
5 on the latest quarter
Facilities
5
0 equity pieces beside them
Next maturity
Jun 21, 2024
$73.3M inside 24 months
On the tape since
Dec 31, 2021
latest Jun 30, 2023
Events
7
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2023, folded to one row per lender
Every BDC piece · 13 positions across 5 lenderslargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
C•••••• C••••• S••••••••• I•••term loan first lien
F•••• L••• D•••
$26.7M$26.5M
100c
S+525 bp
C•••••• S•••••• L••••••• I•••unstated lien unstated$19.8M$19.7M
99c
S+525 bp
M••••• F•••••••• I••••••••• C•••term loan first lien
F•••• L••• S•••••• D••• S•••+540, 1.00% F•••• M••••••• D••• 06/22/24
$17.6M$17.6M
100c
S+540 bp
C••• I••••••••• C•••term loan first lien
S••••• S•••••• F•••• L••• D•••, 6/21/2024 M•••••••
$4.8M$4.8M
100c
S+525 bp
C•••••• S•••••• L••••••• I•••term loan first lien
F•••• L••• D•••
$2.4M$2.4M
100c
S+525 bp
View all 13 positionslargest principal first
BDCInstrumentPrincipalFair valueRate
M••••• F•••••••• I••••••••• C•••revolver first lien
F•••• L••• S•••••• D••• - R••••••• S•••+540, 1.00% F•••• M••••••• D••• 06/22/24
$1.8M$1.4M
100c
S+540 bp
C•••••• C••••• S••••••••• I•••revolver second lien
F•••• and S••••• L••• D••• R•••••••
Not disclosedNot disclosed
C•••••• S•••••• L••••••• I•••revolver second lien
R•••••••
Not disclosedNot disclosedS+525 bp
C•••••• S•••••• L••••••• I•••revolver second lien
F•••• and S••••• L••• D••• R•••••••
Not disclosedNot disclosed
M••••• F•••••••• I••••••••• C•••unstated lien unstatedNot disclosedNot disclosed
M••••• F•••••••• I••••••••• C•••unstated lien unstatedNot disclosed$19.0M
100c
M••••• F•••••••• I••••••••• C•••unstated lien unstatedNot disclosedNot disclosed
M••••• C•••••• C•••term loan first lien
S••••• S•••••• L••••, due 6/24/2024
Not disclosedNot disclosedS+540 bp
Capital structure as the BDCs see it
latest quarter end Jun 30, 2023
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lien
exited Jun 30, 2023
at least $51.6M100cS+525 bpJun 24, 20245
other lien unstated
exited Jun 30, 2023
at least $19.8M100cS+525 bpJun 22, 20242
first lien revolver first lien
exited Jun 30, 2023
at least $1.8M100cS+540 bpJun 22, 20241
second lien revolver second lien
exited Jun 30, 2023
unknownn/aS+525 bpunstated2
revolver lien unstated
exited Mar 31, 2023
unknownn/aS+525 bpunstated1
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20235$73.3M$72.4M100c0
Mar 31, 20234$73.3M$71.7M134c0
Dec 31, 20226$103M$101M98c0
Sep 30, 20222$27.5M$26.8M98c0
All 6 quarters
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Mar 31, 20221$0$0n/a0
Dec 31, 20213$51.7M$51.1M109c0
What changed
Full timeline · 11 events
Every change including routine ones
Identity
Group key
ANALOGICderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 6 BDCsderived
Industry
Healthcare & Pharmaceuticalsreportedas one filer wrote it